We are live on ! Find out more
Name Net increased
positions
Increased positions Reduced positions Return since
31 Mar ‘23
LESL icon
1
Leslie's
LESL
$8.33M
50 117 67 99.6%
DH icon
2
Definitive Healthcare
DH
$77M
36 69 33 92.9%
TTEC icon
3
TTEC Holdings
TTEC
$124M
36 94 58 93.2%
NFE icon
4
New Fortress Energy
NFE
$92.9M
34 98 64 98.9%
EAF icon
5
GrafTech
EAF
$184M
33 85 52 85.5%
DOMO icon
6
Domo
DOMO
$171M
32 64 32 74.4%
FLNA
7
Filana Therapeutics
FLNA
$42M
30 58 28 96.4%
STEM icon
8
Stem
STEM
$44.3M
30 89 59 95.6%
FULC icon
9
Fulcrum Therapeutics
FULC
$241M
29 51 22 27%
BLNK icon
10
Blink Charging
BLNK
$67.5M
29 70 41 94.6%
PLRX icon
11
Pliant Therapeutics
PLRX
$65M
27 57 30 96.1%
MED icon
12
Medifast
MED
$107M
27 107 80 90.7%
INGN icon
13
Inogen
INGN
$174M
26 63 37 48.5%
OTLK icon
14
Outlook Therapeutics
OTLK
$187M
26 34 8 95.4%
DXLG icon
15
Destination XL Group
DXLG
$32.9M
25 59 34 89.2%
CHPT icon
16
ChargePoint
CHPT
$134M
25 127 102 97.5%
LUNG icon
17
Pulmonx
LUNG
$52.8M
24 47 23 88.8%
BMEA icon
18
Biomea Fusion
BMEA
$88.2M
24 31 7 96.1%
UPLD icon
19
Upland Software
UPLD
$13.3M
24 53 29 89.5%
PRPL icon
20
Purple Innovation
PRPL
$34.5M
23 45 22 88%
MXCT icon
21
MaxCyte
MXCT
$108M
23 51 28 79.6%
ORBS
22
Eightco Holdings
ORBS
$225M
22 24 2 97.2%
DAVA icon
23
Endava
DAVA
$165M
22 76 54 95.3%
OWLT icon
24
Owlet
OWLT
$147M
22 26 4 11.2%
KPTI icon
25
Karyopharm Therapeutics
KPTI
$155M
22 52 30 88.2%